AKT1 and breast cancer: Comparison of the AKT1 E17K mutation and the mutation of PIK3CA displays enhanced AKT1 activity in the AKT1 mutation, but elevated activity of AKT1 and AKT2 in the PIK3CA mutated breast cancer cells.